文献速递分子诊断临床微生物临床免疫

T2Resistance 面板在前瞻性血流感染耐药基因检测中的初步研究

Prospective observational pilot study of the T2Resistance panel in the T2Dx system for detection of resistance genes in bacterial bloodstream infections.
PubMed 文献 · J Clin Microbiol · 2024-03-08

本研究在两家大型医疗中心前瞻性纳入 59 例细菌血流感染患者,用 T2Resistance 面板直接从血液中检测耐药基因,并与药敏试验、表型鉴定及标准分子检测比较;T2R 中位阳性时间 4.4 小时,显著短于血培养药敏最终报告 58.34 小时,灵敏度高并可影响抗菌治疗决策。

要点

  • T2R 中位阳性时间 4.4 小时,血培养药敏最终报告 58.34 小时,P<0.0001。
  • T2R 对 blaCTXM-14/15、blaNDM/bla/IMP/blaVIM、blaAmpC、mecA/mecC 灵敏度 100%,blaKPC 87.5%。
  • T2R 结果促使 32 次停用不必要抗生素和 17 次升级抗生素,包括 6 例启动头孢他啶/阿维巴坦。

核心结论

  • T2R 对细菌血流感染耐药基因检测灵敏度高,较标准方法约缩短 90% 的耐药检测时间,并影响抗菌治疗决策。

研究设计与样本

  • 前瞻性观察性初步研究,在两家大型医疗中心纳入 59 例血流感染患者,比较 T2R 与药敏试验、表型鉴定及标准分子检测。

主要发现

  • 59 例中检出 25 个耐药基因:blaKPC n=10,blaNDM/bla/IMP/blaVIM n=5,blaCTXM-14/15 n=4,blaAmpC n=2,mecA/mecC n=4。
  • T2R 中位阳性时间 4.4 小时(IQR 3.65-4.97 小时),血培养药敏最终报告 58.34 小时(IQR 45.51-111.2 小时),P<0.0001。
  • T2R 灵敏度:blaCTXM-14/15、blaNDM/bla/IMP/blaVIM、blaAmpC、mecA/mecC 均为 100%,blaKPC 为 87.5%。
  • 监测到 32 次停用不必要抗生素和 17 次升级抗生素,包括 6 例因 blaKPC 阳性启动头孢他啶/阿维巴坦。

临床怎么用

  • T2R 可快速从血液中检出常见耐药基因,辅助早期调整经验性抗菌治疗。

局限性

  • 本研究为初步观察性研究,样本量 59 例,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Early initiation of antimicrobial therapy targeting resistant bacterial pathogens causing sepsis and bloodstream infections (BSIs) is critical for a successful outcome. The T2Resistance Panel (T2R) detects the following resistance genes within organisms that commonly cause BSIs directly from patient blood samples: blaKPC, blaCTXM-14/15, blaNDM/bla/IMP/blaVIM, blaAmpC, blaOXA, vanA, vanB, and mecA/mecC. We conducted a prospective study in two major medical centers for the detection of circulating resistance genes by T2R in patients with BSIs. T2R reports were compared to antimicrobial susceptibility testing (AST), phenotypic identification, and standard molecular detection assays. Among 59 enrolled patients, 25 resistance genes were identified: blaKPC (n = 10), blaNDM/bla/IMP/blaVIM (n = 5), blaCTXM-14/15 (n = 4), blaAmpC (n = 2), and mecA/mecC (n = 4). Median time-to-positive-T2R in both hospitals was 4.4 hours [interquartile range (IQR): 3.65-4.97 hours] in comparison to that for positive blood cultures with final reporting of AST of 58.34 h (IQR: 45.51-111.2 hours; P < 0.0001). The sensitivity of T2R to detect the following genes in comparison to AST was 100% for blaCTXM-14/15, blaNDM/bla/IMP/blaVIM, blaAmpC, mecA/mecC and 87.5% for blaKPC. When monitored for the impact of significant antimicrobial changes, there were 32 events of discontinuation of unnecessary antibiotics and 17 events of escalation of antibiotics, including initiation of ceftazidime/avibactam in six patients in response to positive T2R results for blaKPC. In summary, T2R markers were highly sensitive for the detection of drug resistance genes in patients with bacterial BSIs, when compared with standard molecular resistance detection systems and phenotypic identification assays while significantly reducing by approximately 90% the time to detection of resistance compared to standard methodology and impacting clinical decisions for antimicrobial therapy. IMPORTANCE: This is the first reported study to our knowledge to identify key bacterial resistance genes directly from the bloodstream within 3 to 5 hours in patients with bloodstream infections and sepsis. The study further demonstrated a direct effect in modifying initial empirical antibacterial therapy in response to T2R signal to treat resistant bacteria causing bloodstream infections and sepsis.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Walsh TJ, Mencacci A, Paggi R, et al. Prospective observational pilot study of the T2Resistance panel in the T2Dx system for detection of resistance genes in bacterial bloodstream infections. J Clin Microbiol. 2024. PMID: 38456690. doi:10.1128/jcm.01296-23

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。